Capstone Investment Advisors
CLB icon

Capstone Investment Advisors’s Core Laboratories CLB Stock Holding History

Capstone Investment Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,300
Closed -$1.14M – 567
2017
Q2 		$1.14M Buy
+11,300
New +$1.22M 0.03% 312
2016
Q4 		– Sell
-26,461
Closed -$2.97M – 941
2016
Q3 		$2.97M Buy
26,461
+11,518
+77% +$1.33M 0.07% 196
2016
Q2 		$1.85M Buy
+14,943
New +$1.8M 0.04% 247

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Capstone Investment Advisors's CLB Position: Q3 2017 in Review

Capstone Investment Advisors sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 11,300 shares — an estimated $1.14M sold.

Capstone Investment Advisors first reported a position in CLB in Q2 2016 and held it in 3 quarters. The position peaked at $2.97M in Q3 2016. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Capstone Investment Advisors reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Capstone Investment Advisors sold 11,300 Core Laboratories shares in Q3 2017, an estimated $1.14M.
  • Capstone Investment Advisors first reported a position in Core Laboratories in Q2 2016 and held it in 3 quarters.
  • Capstone Investment Advisors's Core Laboratories position peaked at $2.97M in Q3 2016.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Capstone Investment Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.